Annual Report

Overview

The report describes Fusen Pharmaceutical's 2025 ESG governance, environmental performance, workforce initiatives and business ethics programme. It places the Board at the highest level of ESG oversight and reports GHG emissions of 3,097.283 tCO2, alongside detailed climate-risk, pollution-control and resource-consumption disclosures. The company reports a Group year-end workforce of 1,005 employees, while the ESG narrative also discusses employee development, safety and inclusion. Its anti-corruption framework covers employees and business partners, with 100% anti-corruption training coverage and no corruption-related whistleblowing reports or litigation cases reported in 2025.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Publication date: 31 March 2026
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services